Nuveen »

ADC Therapeutics SA shares owned by Nuveen

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Nuveen

Quarter filed Position value Share count Share price at filing
2025-09-30 $685k 171k 4.00
2025-06-30 $319k 119k 2.68
2025-03-31 $214k 152k 1.41

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Nuveen

Top funds holding ADC Therapeutics SA

Redmile Group
Point72 Asset Management
Prosight Management
OrbiMed Advisors
BlackRock
Morgan Stanley
Nantahala Capital Management
Goldman Sachs Group
TCG Crossover Management
Lynx1 Capital Management
State Street Corporation
Platinum Investment Mangement
Geode Capital Management
Citadel Advisors
Blue Owl Capital Holdings

View all funds holding ADC Therapeutics SA